Kodiak Sciences, Zenkuda, tarcocimab tedromer, tabirafusp-ted, KSI-501, DAYBREAK Trial, Phase 3 Clinical Trial

Palo Alto, California, U.S., September 28, 2026 Kodiak Sciences Inc. announced that both Zenkuda™ (tarcocimab tedromer) and tabirafusp alfa...